Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 20, 2018
Pharmacy Choice - Pharmacy News - January 20, 2018

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
1/20/18 - Avera To Enroll First Patients in Landmark Lung Cancer Tri-Therapy Clinical Trial [Sudan Tribune]
This clinical trial that received the approval of the FDA is Averas latest collaboration as part its membership in the Worldwide Innovative Networking Consortium. This latest step in our collaboration with WIN represents one clinical trial but is part of our larger goal to revolutionize cancer care through personalized medicine, said Benjamin Solom
1/19/18 - AstraZeneca Announces Approval Of Fasenra In Japan
LONDON- AstraZeneca and MedImmune announced the Japanese Ministry of Health, Labour and Welfare has approved Fasenra as an add-on treatment for bronchial asthma in patients who continue to experience asthma exacerbations despite treatment with high-dose inhaled corticosteroid and other asthma controllers. The Japanese approval follows US FDA...
1/19/18 - Avera To Enroll First Patients in Landmark Lung Cancer Tri-Therapy Clinical Trial
This clinical trial that received the approval of the FDA is Averaâ?? s latest collaboration as part its membership in the Worldwide Innovative Networking Consortium. Through the WIN Consortium, an Avera research team under Solomonâ?? s leadership has helped design and implement the clinical trial from the ground up. â??This breakthrough research i
1/19/18 - Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability
SUMMARY: The Food and Drug Administration is announcing the availability of a guidance for industry entitled "Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under Section 503 B of the Federal Food, Drug, and Cosmetic Act." For a drug product compounded by an outsourcing facility to qualify for the exemptions under se
1/19/18 - EC approves Amgen's biosimilar Avastin
Amgen Inc. and Allergan plc said the European Commission approved Mvasi, a biosimilar of Avastin bevacizumab. In September, FDA approved the drug as Mvasi bevacizumab-awwb for all cancer types on Avastin's U.S. label except ovarian cancer. Roche and its Genentech Inc. unit market Avastin.
1/19/18 - Lupin launches generic Vibra-Tabs tablet in US [India Infoline News Service]
Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablet USP, 100 mg having received an approval from the United States Food and Drug Administration earlier. The stock is currently trading at Rs919, up by Rs0.6 or 0.07% from its previous closing of Rs918.4 on the BSE. The scrip opened at Rs920.25 and has touched a high and low of R

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415